Investigations led from the AstraZeneca graduate programme deliver mechanistic insights and the first predominantly RNA-free guide molecule capable of directing Cas9 gene editing
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.